AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

R6G9 Treatment Improves Viral-Induced Neurological Disease

Technology Application: This antibody may offer an attractive method for reducing CNS inflammation in humans and treating inflammatory demyelinating diseases such as MS.

Detailed Technology Description: Researchers at the University of California, Irvine have identified a monoclonal antibody-based method that decreases immune cell infiltration into the CNS and improves neurological function in a mouse model of MS.

Others: Tech ID/UC Case
18869/2003-266-0

Related Cases
2003-266-0

*Abstract: Multiple Sclerosis (MS) is a devastating neurological disease. MS patients often experience neurologic dysfunction believed to be the result of infiltration of immune cells, inflammation of the central nervous system and eventual nerve damage.

*Principal Investigator: Name: Thomas Lane
Department:

Country/Region: USA

For more information, please click Here